
Shuo Ma, MD, PhD, assistant professor at Northwestern University in the Robert H. Lurie Comprehensive Cancer Center, discusses some of the side effects that come with new agents approved for the treatment of non-Hodgkin Lymphoma.

Shuo Ma, MD, PhD, assistant professor at Northwestern University in the Robert H. Lurie Comprehensive Cancer Center, discusses some of the side effects that come with new agents approved for the treatment of non-Hodgkin Lymphoma.

Kathi Mooney, PhD, RN, FAAN, Louis S. Peery and Janet B. Peery Presidential Endowed Chair in Nursing, College Of Nursing, University of Utah, Co-Leader Cancer Control and Population Sciences, Huntsman Cancer Institute, discusses using an automated remote monitoring system to improve patients' side effects following chemotherapy treatment.

Tracey L. Evans, MD associate professor, clinical medicine, Abramson Cancer Center, University of Pennsylvania Health System, discusses the benefit of advanced lung cancer patients receiving palliative care early in their diagnosis.

Clifford A. Hudis, MD, chief, Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, professor of medicine, Weill Cornell Medical College, discusses the link between obesity and cancer.

Hyman B. Muss, MD, professor of oncology, University of North Carolina, director, Geriatric Oncology, Lineberger Comprehensive Cancer Center, discusses tamoxifen as breast cancer prevention

Deanna J. Attai, MD, breast surgeon, assistant clinical professor of surgery, David Geffen School of Medicine, University of California, Los Angeles, discusses how nurses can help their patients.

Michael Mauro, MD, hematologist and leader of the Myeloproliferative Neoplasms Program, Leukemia Service at Memorial Sloan Kettering Cancer Center, explains why some patients with CML don't adhere to their medication.

Rami S. Komrokji, MD, clinical director, Hematologic Malignancies, Moffitt Cancer Center, discusses the risk factors for developing myelodysplastic syndromes(MDS).

Tara Sanft, MD, assistant professor of medicine (medical oncology), medical director, Adult Survivorship, Yale Cancer Center Survivorship Clinic, discusses the benefit of using a multidisciplinary team when caring for cancer patients.

Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the challenges of managing side effects from immunotherapy treatments.

Gwendolynn Harrell, RN, Palliative Care Nurse Liaison, Supportive Oncology Care Team, Emory University, discusses a study that examined symptom clustering among patients visiting a supportive oncology clinic.

Craig Blinderman, MD, MA, Attending Physician in Medicine & Anesthesiology New York-Presbyterian Hospital/Columbia University Medical Center, Assistant Professor of Palliative Care (Medicine & Anesthesiology), Columbia University, discusses the confusion surrounding the term "palliative care."

Erin W. Hofstatter, MD, assistant professor of medicine (medical oncology), co-director, Genetic Counseling Program, Yale Cancer Center, discusses chemoprevention to reduce one's risk of developing breast cancer.

Margaretta Page, MS, RN, clinical nurse specialist, UCSF School of Medicine, discusses the importance of caring for the caregiver.

Virginia LeBaron, APRN, PhD, FAAN, post-doctoral research fellow, Dana-Farber Cancer Institute, discusses a study that looked at how cancer outpatients and health care providers talk about pain.

Jenna Forsythe, MSN, RN, OCN, a nurse in the leukemia and lymphoma outpatient center at John Theurer Cancer Center, discusses some of the challenges patients with leukemia and lymphoma face.

Kathi Mooney, PhD, RN, FAAN, Louis S. Peery and Janet B. Peery Presidential Endowed Chair in Nursing, College Of Nursing, University of Utah, Co-Leader Cancer Control and Population Sciences, Huntsman Cancer Institute, discusses how technology can be used to improve survivorship care.

Christopher R. Friese, PhD, RN, AOCN, FAAN, assistant professor, Division of System Leadership and Effectiveness Science, University of Michigan School of Nursing, discusses the National Institute for Occupational Safety and Health (NIOSH) $2.3 million research grant that will be used to identify exposure risks.

Linda Casey, BSN, OCN, a nurse at the John Theurer Cancer Center, discusses working with and treating patients who are diagnosed with blood cancer.

Louise Eaton, RN, BSN, OCN, inpatient Stem Cell Transplant Unit, John Theurer Cancer Center, provides advice for the relationship between caregivers and patients undergoing stem cell transplantation, as well as responsibilities for caregivers.

Jack Cuzick, PhD, a professor of epidemiology at Wolfson Institute of Preventive Medicine, discusses how to determine if a woman is at high risk of developing breast cancer and which of these women should consider taking tamoxifen as a preventative measure.

Patricia Ganz, MD, UCLA Jonsson Comprehensive Cancer Center, discusses how to better integrate survivorship plans for patients with cancer.

Jenna Forsythe, MSN, RN, OCN, a nurse in the leukemia and lymphoma outpatient center at John Theurer Cancer Center, discusses updates in leukemia treatment and the effect it has had in practice.

Jean Weigert, MD, head of breast imaging for the Hospital of Central Connecticut, discusses a study conducted in Connecticut to see if the addition of screening breast ultrasound in women with mammographically normal but dense breasts has increased breast cancer detection.

Linda Casey, BSN, OCN, a nurse at the John Theurer Cancer Center, discusses distress screening for patients undergoing cancer treatment.

Kathi Mooney, PhD, RN, FAAN, Louis S. Peery and Janet B. Peery Presidential Endowed Chair in Nursing, College Of Nursing, University of Utah, Co-Leader Cancer Control and Population Sciences, Huntsman Cancer Institute, discusses the importance of improving symptom management in cancer patients.

Louise Eaton, RN, BSN, OCN, inpatient Stem Cell Transplant Unit, John Theurer Cancer Center, gives advice on how nurses should manage patients undergoing stem cell transplantation.

Michelle Gervino, RN, BSN, OCN, John Theurer Cancer Center, discusses side effects that patients with hematologic malignancies may experience during treatment

Joan Lunden talks about imaging technology and genetic testing for the early detection of breast cancer with Roy Firestone and Patrick I. Borgen, MD, in advance of her keynote address at the 32nd Miami Breast Cancer Conference (MBCC).

Joan Lunden discusses the diagnostic approach that led to the early detection of triple-negative breast cancer, which was undetected by mammogram and 3D mammogram but was detected with ultrasound.